SCHEMBL29133723

SCHEMBL29133723

CC[C@]1(Nc2ncnc3ccc(-c4cccc(-c5nnc[nH]5)c4)cc23)C=CC=CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K4 O95819 6/20 0.39
▸ CLK4 Q9HAZ1 11/20 0.36
▸ CYP1A2 P05177 7/20 0.36
▸ CYP3A4 P08684 7/20 0.36
▸ CYP2C19 P33261 7/20 0.36
▸ USP2 O75604 5/20 0.36
▸ CYP2D6 P10635 5/20 0.36
▸ LMNA P02545 5/20 0.36
▸ HSD17B10 Q99714 5/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ CYP2C9 P11712 3/20 0.36
▸ MAPK1 P28482 4/20 0.35
▸ TSHR P16473 3/20 0.35
▸ ALOX15 P16050 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HIF1A Q16665 1/20 0.34
▸ BRAF P15056 2/20 0.34
▸ RAF1 P04049 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133721 0.82 EGFR (0.37) —
SCHEMBL29133795 0.79 NOTUM (0.40) MAP4K4CLK4CYP1A2CYP3A4CYP2C19
SCHEMBL29133728 0.78 IRAK4 (0.48) MAP4K4CLK4CYP1A2CYP3A4CYP2C19
SCHEMBL29133742 0.78 IRAK4 (0.35) MAP4K4CLK4CYP1A2CYP3A4CYP2C19
SCHEMBL29133745 0.76 HTT (0.50) CYP1A2CYP3A4CYP2C19CYP2D6LMNA
SCHEMBL29133739 0.76 HTT (0.50) CYP1A2CYP3A4CYP2C19CYP2D6LMNA
SCHEMBL29133774 0.76 IRAK4 (0.47) MAP4K4CLK4CYP1A2CYP3A4LMNA
SCHEMBL29133752 0.75 HTT (0.36) MAP4K4CLK4LMNASMN1; SMN2
SCHEMBL29133735 0.75 HTT (0.36) MAP4K4CLK4LMNASMN1; SMN2
SCHEMBL29133716 0.75 IRAK4 (0.39) MAP4K4CLK4CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 — — CN disclosed
Send feedback